Programmed Cell Death-1 Inhibitor–Induced Type 1 Diabetes Mellitus-Reference-Cited by-同舟云学术

Programmed Cell Death-1 Inhibitor–Induced Type 1 Diabetes Mellitus

Published:2018-06-27 Issue:9 Volume:103 Page:3144-3154
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Clotman Katrien¹²,Janssens Katleen³,Specenier Pol³⁴,Weets Ilse⁵,De Block Christophe E M¹³

Affiliation:

1. Department of Endocrinology, Diabetology & Metabolism, Antwerp University Hospital, Edegem, Belgium

2. Department of Endocrinology-Nephrology, Algemeen Ziekenhuis Klina Hospital, Brasschaat, Belgium

3. Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium

4. Department of Oncology, Antwerp University Hospital, Edegem, Belgium

5. Diabetes Research Center, Brussels Free University, Brussels, Belgium

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/103/9/3144/25685992/jc.2018-00728.pdf

Reference55 articles.

1. Immune checkpoint inhibitors: review and management of endocrine adverse events;González-Rodríguez;Oncologist,2016

2. Food and Drug Administration. Pembrolizumab prescribing information. Available at: www.accessdata.fda.gov/drugsatfda_docs/label/2016/125514s012lbl.pdf. Accessed 18 March 2018.

3. Releasing the brakes on cancer immunotherapy;Ribas;N Engl J Med,2015

4. Tumor immunotherapy directed at PD-1;Ribas;N Engl J Med,2012

5. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N Engl J Med,2015

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitors-Associated Diabetes and Ketoacidosis Were Found in FDA Adverse Event Reporting System: A Real-World Evidence Database Study;Endocrine Practice;2024-09

2. Endocrine toxicity of cancer immunotherapy;International Journal of Molecular and Immuno Oncology;2024-08-31

3. Identification of Immune Checkpoint Inhibitor–Induced Diabetes;JAMA Oncology;2024-08-29

4. Multiple Endocrine Toxicities in a Metastatic Cutaneous Melanoma Patient Treated with Checkpoint Inhibitors;Journal of Medical and Radiation Oncology;2024-07-27

5. Therapeutic Insulin Analogue Concentrations at Infusion Sites Enhanced the Pro-Inflammatory Response and Apoptosis in an In Vitro Macrophage-Material Interaction Model;ACS Pharmacology & Translational Science;2024-07-03